Transgene SA
TRGNF
$0.70
-$0.89-55.98%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -36.75M | -30.89M | -24.78M | -24.56M | -24.14M |
| Total Depreciation and Amortization | 1.39M | 1.44M | 1.49M | 1.60M | 1.70M |
| Total Amortization of Deferred Charges | 1.50M | 5.12M | 8.77M | 8.77M | 8.77M |
| Total Other Non-Cash Items | -3.24M | -10.38M | -17.57M | -16.87M | -16.18M |
| Change in Net Operating Assets | 11.65M | 2.77M | -6.36M | -7.02M | -7.64M |
| Cash from Operations | -25.46M | -31.95M | -38.45M | -38.09M | -37.50M |
| Capital Expenditure | -3.32M | -3.43M | -3.54M | -3.22M | -2.88M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -152.50K | 9.88M | 20.02M | 30.23M | 40.27M |
| Cash from Investing | -3.47M | 6.44M | 16.49M | 27.01M | 37.39M |
| Total Debt Issued | 0.00 | 10.00M | 20.00M | 10.00M | -- |
| Total Debt Repaid | -1.24M | -1.49M | -1.75M | -1.47M | -1.19M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 28.20M | 20.73M | 13.27M | 12.91M | 12.56M |
| Cash from Financing | 29.15M | 31.65M | 34.09M | 23.24M | 12.31M |
| Foreign Exchange rate Adjustments | 864.40K | 651.70K | 432.40K | 213.30K | -7.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.09M | 6.80M | 12.56M | 12.37M | 12.19M |